Selective effect signal on liver cancer tissue in phase Ia study with MIV-818

Read more

Medivir to present at the 2019 BIO International Convention

Read more

New data from the phase I study of birinapant in combination with Keytruda® presented at ASCO

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.